A unique case of hepatocellular carcinoma treated with radiofrequency ablation with more than 12 years overall survival: a case report.
The case of a 72-year-old male patient with HCC is presented in whom percutaneous RFA was used as the sole first-line anticancer treatment, since he denied having partial hepatectomy. The patient underwent RFA two more times, at 1.5 years for treating a local tumor progression at the initial ablation site and at 11 years after the first session for treating a new remote intrahepatic recurrence. He revealed a long-term survival of more than 12 years so far and still remains in excellent clinical status.
Department of Computed Tomography and Interventional Radiology, "Sotiria" General Hospital of Chest Diseases, Mesogion Avenue 152, 11527 Athens, Greece.
Loukas
L
Thanos
Nikolaos
N
Ptohis
Anastasia
A
Pomoni
Evangelia
E
Sotiropoulou
Maria
M
Pomoni
Dimitrios
D
Kelekis
Radiology. 2003 Feb;226(2):441-51
12563138
Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):289-92
17200902
Semin Liver Dis. 1999;19(3):329-38
10518312
Eur Radiol. 2001;11(6):914-21
11419162
World J Gastroenterol. 2006 Jun 21;12(23):3716-21
16773688
J Surg Res. 2005 Nov;129(1):147-51
15975593
Radiology. 2005 Mar;234(3):961-7
15665226
AJR Am J Roentgenol. 2006 May;186(5 Suppl):S327-33
16632696
World J Gastroenterol. 2006 Jan 28;12(4):546-52
16489666
Radiographics. 2001 Oct;21 Spec No:S17-35; discussion S36-9
11598245
AJR Am J Roentgenol. 2006 May;186(5 Suppl):S261-8
16632686
AJR Am J Roentgenol. 1996 Sep;167(3):759-68
8751696